0001177648-20-000031.txt : 20200806
0001177648-20-000031.hdr.sgml : 20200806
20200806163841
ACCESSION NUMBER: 0001177648-20-000031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200805
FILED AS OF DATE: 20200806
DATE AS OF CHANGE: 20200806
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gardiner Nathaniel S.
CENTRAL INDEX KEY: 0001607643
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35839
FILM NUMBER: 201082320
MAIL ADDRESS:
STREET 1: C/O ENANTA PHARMACEUTICALS, INC.
STREET 2: 500 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENANTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001177648
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 500 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617 607 0800
MAIL ADDRESS:
STREET 1: 500 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-08-05
0001177648
ENANTA PHARMACEUTICALS INC
ENTA
0001607643
Gardiner Nathaniel S.
C/O ENANTA PHARMACEUTICALS, INC.
500 ARSENAL STREET
WATERTOWN
MA
02472
0
1
0
0
Sr. VP & General Counsel
Common Stock
2020-08-05
4
M
0
1666
30
A
29271
D
Common Stock
16645
I
By grantor retained annuity trusts
Stock Option (right to buy)
30
2020-08-05
4
M
0
1666
0
D
2026-11-18
Common Stock
1666
15334
D
These shares are held by grantor retained annuity trusts created by the reporting person for the benefit of himself and his two adult children.
This option to purchase a total of 25,000 shares of common stock became or will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 18, 2016).
/s/ Nathaniel S. Gardiner
2020-08-06